Comparison of 3 Versus 6-Month Use of CGMS in Non-Insulin Using T2DM Patients

Patients not receiving any insulin treatment with an HbA1c ≥ 7.5% before their scheduled
primary care appointment will be invited to participate in the study and wear professional
CGM for at least 3 days at either 3 intervals (baseline, 3-month and 6-month) or 2 intervals
(baseline and 6-month). After removal, the downloaded report will provide quantitative data
to determine the percent of time spent in the target range. The 6-month data will be analyzed
to determine if frequency of professional CGM wear positively affects time spent in target
range.

Inclusion Criteria:

1. 18 years or older with a diagnosis of T2DM with a scheduled office visit with primary
care provider within the next 4 weeks

2. Last 2 HbA1c values between 7.5 - 10% measured in the last 12 months

3. Treated with non-insulin therapies or therapeutic lifestyle changes

4. Never worn professional CGM or have not worn in last 12 months

5. Willing to perform requirements needed for professional CGM

Exclusion Criteria:

1. Current or previous treatment with any insulin within 3 months at baseline